Controlled Trial of Dipyridamole in Cerebral Vascular DiseaseBMJ 1969; 1 doi: http://dx.doi.org/10.1136/bmj.1.5644.614 (Published 08 March 1969) Cite this as: BMJ 1969;1:614
- Joan Acheson,
- G. Danta,
- E. C. Hutchinson
A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.